Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Secondary cancers, Small cell lung cancer
Closed
Phase 3
This trial is looking at a new drug called MK-7684A with chemotherapy to treat small cell lung cancer.
It is for people whose cancer has spread within the chest or to other parts of the body. This is called extensive disease.
Recruitment start: 28 September 2022
Recruitment end: 2 June 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Raffaele Califano
Merck Sharp & Dohme LLC
Last reviewed: 01 Jun 2023
CRUK internal database number: 18361